Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2015

01-04-2015 | Original Article

Helicobacter pylori Infection Activates the Akt–Mdm2–p53 Signaling Pathway in Gastric Epithelial Cells

Authors: Xu Shu, Zhen Yang, Zhong-Hua Li, Lian Chen, Xiao-Dong Zhou, Yong Xie, Nong-Hua Lu

Published in: Digestive Diseases and Sciences | Issue 4/2015

Login to get access

Abstract

Backgrounds and Aims

Although Helicobacter pylori is widely accepted as a causative factor of many gastric diseases, the signaling pathways affected by H. pylori and subsequent effects on cell apoptosis and proliferation remain unclear. Here, we investigated the molecular mechanisms mediating H. pylori infection in gastric epithelial cells.

Methods

Tissues from 160 patients with various gastric diseases with or without H. pylori infection were obtained and analyzed by immunohistochemistry for Akt, pAkt, Mdm2, p53, and Bax expression. In vitro, human gastric epithelial cells, GES-1, were incubated with H. pylori culture filtrates. Cell viability was measured by MTT assay. Apoptosis was evaluated by Annexin V/PI double staining followed by flow cytometry, DNA electrophoresis, and comet assay. mRNA and protein expression was assessed by RT-PCR and Western blot analysis.

Results

In patient tissues, H. pylori infection was associated with significantly elevated levels of pAkt in chronic nonatrophic gastritis (CNAG), Mdm2 in dysplasia, p53 in metaplastic atrophy (MA), and Bax in CNAG and MA. In vitro, H. pylori culture filtrates reduced GES-1 cell viability in a time- and dose-dependent manner, induced G0/G1 arrest, triggered apoptosis, and increased DNA fragmentation. Mdm2 and Bax mRNA expression and pAkt, Mdm2, p53, and Bax protein expression were significantly upregulated when treated with H. pylori culture filtrates. Akt inhibition by LY294002 decreased Mdm2 expression, upregulated p53, and enhanced H. pylori-induced growth inhibition of GES-1 cells.

Conclusions

These findings suggest that Akt–Mdm2–p53 signaling is involved in the molecular response of GES-1 cells to H. pylori infection.
Literature
1.
go back to reference Misiewicz JJ. Management of Helicobacter pylori-related disorders. Eur J Gastroenterol Hepatol. 2012;9:S17–S20. (discussion S20-11).CrossRefPubMed Misiewicz JJ. Management of Helicobacter pylori-related disorders. Eur J Gastroenterol Hepatol. 2012;9:S17–S20. (discussion S20-11).CrossRefPubMed
3.
go back to reference Lynch DA, Mapstone NP, Clarke AM, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 1995;36:346–350.CrossRefPubMedCentralPubMed Lynch DA, Mapstone NP, Clarke AM, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 1995;36:346–350.CrossRefPubMedCentralPubMed
4.
go back to reference Li N, Han L, Chen J, Lin X, Chen H, She F. Proliferative and apoptotic effects of gastric epithelial cells induced by coccoid Helicobacter pylori. J Basic Microbiol. 2013;53:147–155.CrossRefPubMed Li N, Han L, Chen J, Lin X, Chen H, She F. Proliferative and apoptotic effects of gastric epithelial cells induced by coccoid Helicobacter pylori. J Basic Microbiol. 2013;53:147–155.CrossRefPubMed
5.
go back to reference Saadat I, Higashi H, Obuse C, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333.CrossRefPubMed Saadat I, Higashi H, Obuse C, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333.CrossRefPubMed
6.
go back to reference Ding SZ, Minohara Y, Fan XJ, et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun. 2007;75:4030–4039.CrossRefPubMedCentralPubMed Ding SZ, Minohara Y, Fan XJ, et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun. 2007;75:4030–4039.CrossRefPubMedCentralPubMed
7.
go back to reference Calvino-Fernandez M, Benito-Martinez S, Parra-Cid T. Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis. 2008;13:1267–1280.CrossRefPubMed Calvino-Fernandez M, Benito-Martinez S, Parra-Cid T. Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis. 2008;13:1267–1280.CrossRefPubMed
8.
go back to reference Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci. 2002;27:462–467.CrossRefPubMed Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci. 2002;27:462–467.CrossRefPubMed
10.
go back to reference Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene. 2005;24:2899–2908.CrossRefPubMed Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene. 2005;24:2899–2908.CrossRefPubMed
11.
go back to reference Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell. 2001;8:317–325.CrossRefPubMed Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell. 2001;8:317–325.CrossRefPubMed
12.
13.
go back to reference Wei J, Nagy TA, Vilgelm A, et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology. 2010;139:1333–1343.CrossRefPubMedCentralPubMed Wei J, Nagy TA, Vilgelm A, et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology. 2010;139:1333–1343.CrossRefPubMedCentralPubMed
14.
go back to reference Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol. 2001;7:779–782.PubMed Zhang Z, Yuan Y, Gao H, Dong M, Wang L, Gong YH. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol. 2001;7:779–782.PubMed
15.
go back to reference Zhang ZW, Patchett SE, Farthing MJ. Role of Helicobacter pylori and p53 in regulation of gastric epithelial cell cycle phase progression. Dig Dis Sci. 2002;47:987–995.CrossRefPubMed Zhang ZW, Patchett SE, Farthing MJ. Role of Helicobacter pylori and p53 in regulation of gastric epithelial cell cycle phase progression. Dig Dis Sci. 2002;47:987–995.CrossRefPubMed
16.
go back to reference Yang Z, Shu X, Chen L, Chen J, Xie Y, Lu NH. Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. Clin Res Hepatol Gastroenterol. 2012;36:235–243.CrossRefPubMed Yang Z, Shu X, Chen L, Chen J, Xie Y, Lu NH. Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. Clin Res Hepatol Gastroenterol. 2012;36:235–243.CrossRefPubMed
17.
go back to reference Hamilton SRAL. Pathology and genetics of tumours of the digestive system. In: World Health Organization classification of tumors. Lyon: IARCP; 2000. Hamilton SRAL. Pathology and genetics of tumours of the digestive system. In: World Health Organization classification of tumors. Lyon: IARCP; 2000.
18.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. The Am J Surg Pathol. 1996;20:1161–1181.CrossRef Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. The Am J Surg Pathol. 1996;20:1161–1181.CrossRef
19.
go back to reference Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1:23–29.CrossRefPubMed Olive PL, Banath JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1:23–29.CrossRefPubMed
20.
go back to reference Sasaki T, Kuniyasu H, Luo Y, et al. Increased phosphorylation of AKT in high-risk gastric mucosa. Anticancer Res. 2013;33:3295–3300.PubMed Sasaki T, Kuniyasu H, Luo Y, et al. Increased phosphorylation of AKT in high-risk gastric mucosa. Anticancer Res. 2013;33:3295–3300.PubMed
21.
go back to reference Kodama M, Fujioka T, Murakami K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol. 2005;20:941–946.CrossRefPubMed Kodama M, Fujioka T, Murakami K, et al. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J Gastroenterol Hepatol. 2005;20:941–946.CrossRefPubMed
22.
go back to reference Nakajima N, Ito Y, Yokoyama K, et al. The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr. 2009;44:196–202.CrossRefPubMedCentralPubMed Nakajima N, Ito Y, Yokoyama K, et al. The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr. 2009;44:196–202.CrossRefPubMedCentralPubMed
23.
go back to reference Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H. pylori-associated chronic gastritis. World J Gastroenterol. 2007;13:1541–1546.CrossRefPubMedCentralPubMed Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H. pylori-associated chronic gastritis. World J Gastroenterol. 2007;13:1541–1546.CrossRefPubMedCentralPubMed
24.
go back to reference Unger Z, Molnar B, Pronai L, Szaleczky E, Zagoni T, Tulassay Z. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol. 2003;15:389–393.CrossRefPubMed Unger Z, Molnar B, Pronai L, Szaleczky E, Zagoni T, Tulassay Z. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol. 2003;15:389–393.CrossRefPubMed
25.
go back to reference Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis. 2000;21:1111–1115.CrossRefPubMed Obst B, Wagner S, Sewing KF, Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis. 2000;21:1111–1115.CrossRefPubMed
26.
go back to reference Kuribayashi K, Finnberg N, Jeffers JR, Zambetti GP, El-Deiry WS. The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo. Cell Cycle. 2011;10:2380–2389.CrossRefPubMedCentralPubMed Kuribayashi K, Finnberg N, Jeffers JR, Zambetti GP, El-Deiry WS. The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo. Cell Cycle. 2011;10:2380–2389.CrossRefPubMedCentralPubMed
27.
go back to reference Bartchewsky W Jr, Martini MR, Squassoni AC, et al. Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer. Dig Dis Sci. 2010;55:111–116.CrossRefPubMed Bartchewsky W Jr, Martini MR, Squassoni AC, et al. Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer. Dig Dis Sci. 2010;55:111–116.CrossRefPubMed
28.
go back to reference Wei J, O’Brien D, Vilgelm A, et al. Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology. 2008;134:1412–1423.CrossRefPubMedCentralPubMed Wei J, O’Brien D, Vilgelm A, et al. Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology. 2008;134:1412–1423.CrossRefPubMedCentralPubMed
29.
go back to reference Soond SM, Carroll C, Townsend PA, et al. STAT1 regulates p73-mediated Bax gene expression. FEBS Lett. 2007;581:1217–1226.CrossRefPubMed Soond SM, Carroll C, Townsend PA, et al. STAT1 regulates p73-mediated Bax gene expression. FEBS Lett. 2007;581:1217–1226.CrossRefPubMed
30.
go back to reference Yan YG, Zhao G, Ma JP, Cai SR, Zhan WH. Effects of different Helicobacter pylori culture filtrates on growth of gastric epithelial cells. World J Gastroenterol. 2008;14:3745–3749.PubMedCentralPubMed Yan YG, Zhao G, Ma JP, Cai SR, Zhan WH. Effects of different Helicobacter pylori culture filtrates on growth of gastric epithelial cells. World J Gastroenterol. 2008;14:3745–3749.PubMedCentralPubMed
31.
go back to reference Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM Jr. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis. 2009;199:641–651.CrossRefPubMedCentralPubMed Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM Jr. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis. 2009;199:641–651.CrossRefPubMedCentralPubMed
32.
go back to reference Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007;73:1697–1702.CrossRefPubMed Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007;73:1697–1702.CrossRefPubMed
33.
go back to reference Takahashi K, Miyashita M, Makino H, et al. Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. Exp Mol Pathol. 2009;87:42–47.CrossRefPubMed Takahashi K, Miyashita M, Makino H, et al. Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. Exp Mol Pathol. 2009;87:42–47.CrossRefPubMed
34.
go back to reference Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501.CrossRefPubMed Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501.CrossRefPubMed
35.
go back to reference Lee JS, Cho JY, Song H, Kim EH, Hahm KB. Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling. J Clin Biochem Nutr. 2012;51:77–83.CrossRefPubMedCentralPubMed Lee JS, Cho JY, Song H, Kim EH, Hahm KB. Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling. J Clin Biochem Nutr. 2012;51:77–83.CrossRefPubMedCentralPubMed
36.
go back to reference Nogueira V, Park Y, Chen CC, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008;14:458–470.CrossRefPubMedCentralPubMed Nogueira V, Park Y, Chen CC, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008;14:458–470.CrossRefPubMedCentralPubMed
Metadata
Title
Helicobacter pylori Infection Activates the Akt–Mdm2–p53 Signaling Pathway in Gastric Epithelial Cells
Authors
Xu Shu
Zhen Yang
Zhong-Hua Li
Lian Chen
Xiao-Dong Zhou
Yong Xie
Nong-Hua Lu
Publication date
01-04-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3470-2

Other articles of this Issue 4/2015

Digestive Diseases and Sciences 4/2015 Go to the issue

GRG PROFILES AND PERSPECTIVES

GRG Profiles: Lawrence S. Friedman

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine